Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05898399 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05898399 · ClinicalTrials.gov record · last posted 2026-05-01

Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)

StatusRecruiting
PhasePhase 1/2
Started2023-06-30
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This interventional study will evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ART6043 as monotherapy or in combination with olaparib.

Amendment record 6 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 6 times since 2023-06-01; most recent amendment 2026-04-27. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2026-04-27
Status change Active, Not Recruiting→Recruitingv6
2025-10-13
Status change Recruiting→Active, Not Recruitingv5
2023-07-12
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT05898399
Lead Sponsor Artios Pharma Ltd
Conditions Advanced Solid Tumor, Metastatic Solid Tumor
Enrollment 181 participants
Start Date 2023-06-30
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-01